{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:37:48Z","timestamp":1789749468545,"version":"4.0.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.ejogrb.2004.07.010","type":"journal-article","created":{"date-parts":[[2004,10,20]],"date-time":"2004-10-20T05:40:02Z","timestamp":1098250802000},"page":"S15-S17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S","title":["Cyclic nucleotide phosphodiesterase-4 inhibitors: a promising therapeutic approach to premature birth?"],"prefix":"10.1016","volume":"117","author":[{"given":"C\u00e9line","family":"M\u00e9hats","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Oger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Jos\u00e8phe","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2004.07.010_bib1","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJM200005183422007","article-title":"Intrauterine infection and preterm delivery","volume":"342","author":"Goldenberg","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejogrb.2004.07.010_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/153537020122600302","article-title":"Cross talk between cyclic nucleotides and polyphosphoinositide hydrolysis, protein kinases, and contraction in smooth muscle","volume":"226","author":"Abdel-Latif","year":"2001","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ejogrb.2004.07.010_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6603(08)60718-7","article-title":"The molecular biology of cyclic nucleotide phosphodiesterases","volume":"63","author":"Conti","year":"1999","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"10.1016\/j.ejogrb.2004.07.010_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0898-6568(94)90087-6","article-title":"Isolation and characterization of the rolipram-sensitive cyclic AMP-specific phosphodiesterase (type IV PDE) in human term myometrium","volume":"6","author":"Leroy","year":"1994","journal-title":"Cell Signalling"},{"key":"10.1016\/j.ejogrb.2004.07.010_bib5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0022-3565(24)35356-X","article-title":"Pregnancy induces a modulation of the cAMP phosphodiesterase 4-conformers ratio in human myometrium: consequences for the utero-relaxant effect of PDE4-selective inhibitors","volume":"292","author":"Mehats","year":"2000","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1016\/j.ejogrb.2004.07.010_bib6","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1074\/jbc.R200029200","article-title":"Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling","volume":"278","author":"Conti","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejogrb.2004.07.010_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0079-6603(01)69049-4","article-title":"PDE4 cAMP-specific phosphodiesterases","volume":"69","author":"Houslay","year":"2001","journal-title":"Prog. Nucleic. Acid. Res. Mol. Biol."},{"key":"10.1016\/j.ejogrb.2004.07.010_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0898-6568(98)00028-X","article-title":"Effect of pregnancy on PDE4 cAMP-specific phosphodiesterase messenger ribonucleic acid expression in human myometrium","volume":"11","author":"Leroy","year":"1999","journal-title":"Cell Signalling"},{"key":"10.1016\/j.ejogrb.2004.07.010_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0006-2952(89)90142-1","article-title":"Correlation between selective inhibition of the cyclic nucleotide phosphodiesterases and the contractile activity in human pregnant myometrium near term","volume":"38","author":"Leroy","year":"1989","journal-title":"Biochem Pharmacol."},{"key":"10.1016\/j.ejogrb.2004.07.010_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0002-9378(85)90310-2","article-title":"Beta-adrenergic receptors in human myometrium during pregnancy: changes in the number of receptors after beta-mimetic treatment","volume":"151","author":"Berg","year":"1985","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.ejogrb.2004.07.010_bib11","first-page":"5358","article-title":"Is up-regulation of phosphodiesterase 4 activity by PGE2 involved in the desensitization of beta-mimetics in late pregnancy human myometrium?","volume":"86","author":"Mehats","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2004.07.010_bib12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1095\/biolreprod.102.008367","article-title":"Contraction of cultured human uterine smooth muscle cells after stimulation with endothelin-1","volume":"68","author":"Dallot","year":"2003","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.ejogrb.2004.07.010_bib13","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1210\/endo.140.7.6847","article-title":"Selective up-regulation of phosphodiesterase-4 cyclic adenosine 3\u2032,5\u2032-monophosphate (cAMP)-specific phosphodiesterase variants by elevated cAMP content in human myometrial cells in culture","volume":"140","author":"Mehats","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejogrb.2004.07.010_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1164\/ajrccm.157.2.9708012","article-title":"Phosphodiesterase isozymes: molecular targets for novel antiasthma agents","volume":"157","author":"Torphy","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejogrb.2004.07.010_bib15","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1210\/jc.2002-020575","article-title":"Interleukin-1beta induces phosphodiesterase 4B2 expression in human myometrial cells through a prostaglandin E2-cyclic adenosine 3\u2019\u20135\u2019-monophosphate-dependent pathway","volume":"87","author":"Oger","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ejogrb.2004.07.010_bib16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1095\/biolreprod.103.023051","article-title":"Anti-inflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors","volume":"70","author":"Oger","year":"2004","journal-title":"Biol. Reprod."}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211504004105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211504004105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:11:52Z","timestamp":1759554712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211504004105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":16,"alternative-id":["S0301211504004105"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2004.07.010","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclic nucleotide phosphodiesterase-4 inhibitors: a promising therapeutic approach to premature birth?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2004.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}